How Long Does LSD Stay in Your System?

How long LSD stays in your system depends entirely on which test is used. LSD itself clears the body within roughly 24 hours, while its main metabolite stays detectable for up to 4 days.

Blood testing detects LSD for 6 to 12 hours, urine testing for 1 to 4 days, and saliva testing for up to 24 hours. Hair follicle testing reaches back 90 days.

Standard workplace drug panels do not screen for LSD at all. Detection requires a dedicated assay that targets the metabolite 2-oxo-3-hydroxy-LSD rather than the parent compound.

Key Takeaways

• LSD has a plasma half-life of roughly 2.6 to 3.6 hours, meaning the drug itself clears most bodies within about 24 hours.
• Only about 1% of an LSD dose exits the body unchanged, while researchers recovered close to 16% as the metabolite 2-oxo-3-hydroxy-LSD (Dolder et al., 2023).
• Subjective effects last 8.2 hours at 100 micrograms and stretch to 11.6 hours at 200 micrograms, according to controlled dosing research.
• LSD does not appear on standard 5-panel, 10-panel, or 12-panel workplace drug screens.
• LSD is water soluble and is not stored in the spine or fat tissue, so it does not remain in your body for life.

LSD Half-Life and How the Body Clears It

The liver oxidizes LSD into inactive metabolites and the kidneys excrete them. Controlled dosing studies place the elimination half-life at 3.6 to 4.0 hours, which removes the active compound from plasma within approximately 18 to 24 hours in adults with normal hepatic and renal function.

LSD reaches peak plasma concentration 1.5 to 1.7 hours after an oral dose. Concentrations then decline following first-order elimination kinetics, meaning the body removes a fixed percentage of the remaining drug per unit of time.

Dolder and colleagues measured a half-life of 3.6 hours across the first 12 hours and a slower terminal half-life of 8.9 hours afterward. Clinical pharmacology treats four to five half-lives as near-complete clearance, which produces the roughly 24-hour figure.

Metabolites outlast the parent drug by days. That single fact explains why blood detection closes inside half a day while urine detection stretches across most of a week for heavy users.

LSD produces its perceptual effects through partial agonism at the 5-HT2A serotonin receptor. Albert Hofmann first synthesized the compound in 1938 and documented its psychoactive properties in 1943, and it remains a Schedule I substance under federal law.

How long is LSD detectable on each type of drug test?

LSD and its metabolite remain detectable for 6 to 12 hours in blood, 1 to 4 days in urine, up to 24 hours in saliva, and up to 90 days in hair. Ranges below reflect single recreational doses in adults with normal liver and kidney function.

Test type	Detection window	Clinical notes
Blood	6 to 12 hours	Extends to 24 hours on sensitive LC-MS/MS instrumentation
Urine	1 to 4 days	Most common matrix; specialized methods reach 5 days
Saliva	Up to 24 hours	Short window; oral fluid assays for LSD are poorly validated
Hair follicle	Up to 90 days	Reflects a 1.5-inch sample; used forensically, rarely by employers

The clearance sequence below tracks a single oral dose from ingestion through the close of each detection window.

1. 0 to 90 minutes: Absorption completes and perceptual effects begin.
2. 1.5 to 1.7 hours: Plasma LSD reaches peak concentration.
3. 6 to 12 hours: Routine blood assays lose the parent compound.
4. 12 to 24 hours: Plasma LSD falls below the 0.1 nanogram per milliliter quantification limit in most subjects.
5. 24 to 96 hours: Urine assays continue reporting 2-oxo-3-hydroxy-LSD.
6. Up to 90 days: Hair shaft analysis recovers deposited metabolite.

How long does LSD stay in urine?

Urine detects LSD metabolites for 1 to 4 days after a single dose, and specialized laboratory methods occasionally reach 5 days. Urine is the standard matrix because O-H-LSD concentrates there at measurable levels.

Parent LSD alone drops below detection thresholds within 24 hours. Frequent users and larger doses push results toward the four-day end, while a single low-dose tab often reads negative by 48 hours.

How long does LSD stay in blood?

Blood detects LSD for 6 to 12 hours and reaches 24 hours on highly sensitive instrumentation. The narrow window tracks the short plasma half-life directly.

Employers almost never order blood draws for LSD. Emergency medicine and forensic investigation use the matrix when recent impairment is the specific question under examination.

How long does LSD stay in saliva?

Saliva detects LSD for up to 24 hours after ingestion. Oral fluid collection is simple and observable, which is why the method dominates cannabis and stimulant screening.

Validated saliva assays for hallucinogens remain uncommon. Laboratories offering the panel report narrower confidence than urine testing for the same specimen.

How long does LSD stay in hair?

Hair follicle testing detects LSD for up to 90 days, matching the standard lookback of a 1.5-inch sample taken at the scalp. Metabolites incorporate into the shaft through the bloodstream as hair grows.

Microgram dosing makes the method technically demanding and expensive. Courts and forensic laboratories order hair analysis for LSD far more often than employers do.

What do LSD drug tests actually detect?

LSD drug tests detect 2-oxo-3-hydroxy-LSD, the inactive metabolite the liver produces, rather than LSD itself. Hepatic oxidation converts more than 99% of an oral dose before renal excretion, which leaves too little parent compound in urine for a reliable measurement.

Holze and colleagues recovered 1% of an administered dose as unchanged LSD and 16% as 2-oxo-3-hydroxy-LSD, abbreviated O-H-LSD, within the first 24 hours. Dolder and colleagues reported 13% metabolite recovery at a single 200 microgram dose in 2015.

That concentration gap makes urine testing viable. Forensic laboratories quantify O-H-LSD at levels 16 to 43 times higher than LSD in the same specimen, and the metabolite stays measurable for longer.

Two additional compounds appear in LSD-positive urine. Iso-LSD enters the specimen as a synthesis contaminant from street product, and N-desmethyl-LSD, also called nor-LSD, forms through hepatic demethylation.

Does LSD show up on a 5-panel, 10-panel, or 12-panel drug test?

LSD appears on none of the standard 5-panel, 10-panel, or 12-panel drug screens. Those panels target amphetamines, opiates, cocaine metabolites, cannabis, phencyclidine, and benzodiazepines. Detecting LSD requires a dedicated immunoassay plus chromatographic confirmation ordered separately.

Confirmation runs through gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry. The Drug Enforcement Administration LSD fact sheet classifies the compound as Schedule I, and the microgram dose range keeps urine concentrations in the picogram per milliliter band.

A negative routine panel therefore carries no information about LSD use. Absence of a positive result proves nothing when the assay never screened for the compound in the first place.

Does acid stay in your spine or fat tissue forever?

LSD does not deposit in the spinal cord, fat tissue, or any other body compartment. LSD is water soluble, the liver metabolizes it within hours, and the kidneys excrete the metabolites. The permanent storage claim has no pharmacological basis.

Fat-soluble compounds behave differently. THC partitions into adipose tissue and releases slowly over weeks, which produces the 30-day urine windows seen in chronic cannabis users and likely seeded the LSD myth.

Flashbacks are the second source of confusion. Recurrent visual disturbances after hallucinogens meet DSM-5-TR criteria for hallucinogen persisting perception disorder, a perceptual condition of the visual processing system rather than evidence of retained drug.

"Flashbacks and ongoing perceptual disturbances after LSD use are real, but they are not permanent drug residue. They're a diagnosable, treatable condition, and the psychiatric evaluation in the first 24 hours is what separates HPPD from an emerging primary psychiatric disorder. That distinction changes the entire treatment plan."

— Rebecca Littlejohn, MSN, APRN, PMHNP-BC, Medical Provider, South Carolina Addiction Treatment

Internal outcomes data at South Carolina Addiction Treatment from January 2025 to April 2026 show a 34% average decrease in anxiety among clients who complete treatment, and 82% of clients who begin treatment complete it.

What affects how long LSD stays in the body?

Dose size, use frequency, hepatic function, and renal function drive most of the variation in LSD clearance. These variables move a person toward the short or long end of published detection ranges without producing a predictable individual clearance time.

Factors that extend or shorten LSD detection windows:

• Dose taken: Higher microgram doses generate proportionally more metabolite for renal excretion. Holze and colleagues confirmed that urinary recovery scales directly with dose.
• Frequency of use: Repeated dosing across consecutive days accumulates O-H-LSD faster than the kidneys clear it, extending the urine window.
• Liver function: Hepatic oxidation drives LSD breakdown, so cirrhosis, hepatitis, and alcohol-related liver damage slow elimination measurably.
• Kidney function: Renal excretion removes the metabolites, and reduced glomerular filtration lengthens the detection window.
• Age and metabolic rate: Adults over 60 clear hepatically metabolized drugs more slowly than adults in their twenties.
• Polysubstance use: Co-ingested drugs compete for the same hepatic enzymes, and CYP2D6 slow metabolizers process LSD at a reduced rate.
• Hydration and body composition: These shift urine concentration and distribution volume, which alters whether a specimen crosses the laboratory cutoff.

Can a person flush LSD out of their system faster?

No fluid, supplement, or commercial detox product accelerates LSD clearance. Hepatic metabolism sets the elimination rate, and no consumer product alters enzyme kinetics. Time remains the only variable that changes a test result.

Excessive water intake carries documented medical risk. Hyponatremia, a dangerous drop in serum sodium, produces seizures and cerebral edema, and fatal cases have occurred among people consuming large volumes before a scheduled screen.

Laboratories also test specimen validity as a matter of routine. Creatinine and specific gravity measurements flag dilute samples, which triggers a repeat collection under observation.

Getting Help With Hallucinogen Use Disorder

Hallucinogen use rarely presents alone. Repeated LSD use frequently accompanies alcohol use disorder or stimulant use disorder, because shared reward-pathway vulnerability and the same social contexts drive both patterns.

South Carolina Addiction Treatment operates a 16-bed CARF-accredited facility in Simpsonville, South Carolina, serving Greenville County adults aged 18 and older. The center holds licenses from the South Carolina Department of Public Health and the South Carolina Department of Agriculture, and licensed clinical staff cover the campus 24 hours a day.

Medical Detox

The medical detox program provides round-the-clock nursing supervision for clients withdrawing from alcohol, opioids, benzodiazepines, or stimulants. Medical providers administer comfort medication as symptoms present and stabilize clients before clinical programming begins.

Inpatient Rehab

The inpatient rehab program runs a minimum of three therapy groups daily alongside individual counseling and optional family sessions. Programming includes CBT, DBT, motivational interviewing, trauma-informed care, and weekly external offerings such as yoga and art therapy.

Frequently Asked Questions

Can LSD show up on a probation or court-ordered drug test?

Court-ordered and probation panels detect LSD only when the ordering agency requests a dedicated LSD assay. Standard supervision panels screen for amphetamines, opiates, cocaine, cannabis, and benzodiazepines. Forensic laboratories add chromatographic confirmation for 2-oxo-3-hydroxy-LSD when hallucinogen use is specifically alleged.

Can a hair test prove exactly when someone took LSD?

Hair testing establishes a 90-day exposure window rather than a specific date. Segmental analysis divides the shaft into monthly sections and narrows exposure to roughly 30-day bands. Microgram dosing places LSD concentrations near assay detection limits, which makes segmental dating less reliable than for cocaine or opioids.

Do LSD microdoses show up on a drug test?

Microdoses of 5 to 20 micrograms generate metabolite concentrations that fall below most laboratory cutoffs. Forensic chromatography methods quantify 2-oxo-3-hydroxy-LSD down to 10 picograms per milliliter and detect microdoses within 24 hours. Routine immunoassay screening misses them entirely.

Does mixing LSD with other drugs change detection time?

Polysubstance use extends LSD detection when co-ingested drugs compete for the same hepatic enzymes and slow oxidation. Alcohol and cannabis add their own detection windows on separate assays. Combining LSD with MDMA, a pattern known as candy flipping, produces two distinct metabolite profiles that laboratories report separately.

References

1. Holze, F., Erne, L., Duthaler, U., & Liechti, M. E. (2024). Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants. British Journal of Clinical Pharmacology, 90(1), 200–208. https://pubmed.ncbi.nlm.nih.gov/37596682/
2. Dolder, P. C., Schmid, Y., Haschke, M., Rentsch, K. M., & Liechti, M. E. (2015). Pharmacokinetics and concentration-effect relationship of oral LSD in humans. International Journal of Neuropsychopharmacology, 19(1), pyv072.
3. Dolder, P. C., Schmid, Y., Steuer, A. E., Kraemer, T., Rentsch, K. M., Hammann, F., & Liechti, M. E. (2017). Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects. Clinical Pharmacokinetics, 56(10), 1219–1230.
4. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
5. Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics, 14(4), 295–314. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494066/
6. Drug Enforcement Administration. (n.d.). Lysergic acid diethylamide (LSD) drug fact sheet. U.S. Department of Justice. https://www.dea.gov/factsheets/lsd